JNJ-67896062/ACT-064922 ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
86肺動脈性肺高血圧症1

86. 肺動脈性肺高血圧症


臨床試験数 : 1,205 薬物数 : 684 - (DrugBank : 124) / 標的遺伝子数 : 100 - 標的パスウェイ数 : 193
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2022-002754-74-PL
(EUCTR)
15/11/2022Macitentan pharmacokinetics (PK) in children below 2 years of ageA multicenter, open-label, single-arm study to assess the pharmacokinetics and safety of macitentan in children aged 1 month to <2 years with pulmonary arterial hypertension Pulmonary Arterial Hypertension
MedDRA version: 21.1;Level: PT;Classification code 10064911;Term: Pulmonary arterial hypertension;System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
Product Name: Macitentan
Product Code: JNJ-67896062/ACT-064922
INN or Proposed INN: Macitentan
Other descriptive name: ACT-064992
Product Name: Macitentan
Product Code: JNJ-67896062/ACT-064922
INN or Proposed INN: Macitentan
Other descriptive name: ACT-064992
ACTELION Pharmacteuticals Ltd.NULLNAFemale: yes
Male: yes
10Phase 1Turkey;Belgium;United States;Poland;Italy;Germany;Spain